Trileptal 600 mg النرويج - النرويجية - Statens legemiddelverk

trileptal 600 mg

2care4 aps - okskarbazepin - tablett, filmdrasjert - 600 mg

Trileptal 600 mg النرويج - النرويجية - Statens legemiddelverk

trileptal 600 mg

orifarm as - okskarbazepin - tablett, filmdrasjert - 600 mg

Trileptal 600 mg النرويج - النرويجية - Statens legemiddelverk

trileptal 600 mg

orifarm as - okskarbazepin - tablett, filmdrasjert - 600 mg

Trileptal 600 mg النرويج - النرويجية - Statens legemiddelverk

trileptal 600 mg

2care4 aps - okskarbazepin - tablett, filmdrasjert - 600 mg

Inovelon الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

inovelon

eisai gmbh - rufinamide - epilepsi - antiepileptics, - inovelon er indisert som tilleggsbehandling ved behandling av anfall assosiert med lennox gastaut syndrom hos pasienter som er 4 år og eldre.

Lacosamide Accord الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

lacosamide accord

accord healthcare s.l.u. - lakosamid - epilepsi - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Ontozry الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

ontozry

angelini pharma s.p.a - cenobamate - epilepsi - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.